Physical Activity Level and Cognitive Functions in Children With Duchenne Muscular Dystrophy

Launched by MUŞ ALPARSLAN UNIVERSITY · Nov 29, 2022

Keywords

ClinConnect Summary

This clinical trial is studying how physical activity affects thinking and learning abilities in children with Duchenne Muscular Dystrophy (DMD). DMD is a condition that weakens muscles over time, and while we know that being less active can impact physical abilities, we want to understand if it also affects how children think and learn. The researchers are currently looking for children aged 8 to 14 who have been diagnosed with DMD and can follow simple instructions.

To participate, children should be at a certain level of physical function (levels 1-5 on the Brooke classification), which relates to their ability to move. However, those with other serious health issues, who are less physically able than level 5, or who can't cooperate during the tests will not be included. Kids who join the study will help researchers learn more about the connection between staying active and cognitive skills, which could lead to better support for children with DMD in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Children who diagnosed with Duchenne Muscular Dystrophy (DMD), between the ages of 8-14, to have cognitive functions at a level to understand and apply test directives, Level 1-5 according to Brooke lower extremity functional classification will be included.
• Exclusion Criteria:
• • Children who have any chronic or systemic disease in addition to DMD, being above level 5 according to the Brooke lower extremity functional classification, have a cooperation problem, have had any lower/upper extremity injury and/or surgery in the last 6 months and children who did not give consent will be excluded.

Trial Officials